DPP-1 Inhibitors are used to treat inflammatory diseases caused by excessive neutrophil activity, including non-cystic fibrosis bronchiectasis. They work by binding to the DPP-1 enzyme and obstructing its activity, which reduces the activity of neutrophils.
Brinsupri is part of the DPP-1 Inhibitors class and treats Non-Cystic Fibrosis Bronchiectasis. DPP-1 Inhibitors are used to treat inflammatory diseases caused by excessive neutrophil activity, including non-cystic fibrosis bronchiectasis. They work by binding to the DPP-1 enzyme and obstructing its activity, which reduces the activity of neutrophils. Brinsupri is only available as a brand name drug.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up